RHC´s English language broadcast for August 19, 2020
National and International news, with an update of COVID-19 epidemic in Cuba and around the world. Cuba should conclude clinical trials of "Soberana 01" -- a vaccine candidate against COVID-19 -- by early next year. The Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) has approved the submission of a prophylactic drug against the SARS-CoV-2 coronavirus, developed by the Finlay Institute of Vaccines, for Phase I/II studies. The process will begin on August 24th and end on January 11, 2021, according to the Cuban Public Registry of Clinical Trials website. The research to develop the immunizing drug covers 676 people between the ages of 19 and 80 and will be carried out in a "randomized, controlled, adaptive and multicenter way with the aim of evaluating the safety, reactogenicity and immunogenicity of the candidate in a two-dose scheme."